På arendalsuka.no bruker vi informasjonskapsler (cookies). Når du bruker vår nettside godkjenner du dette.
 
Utskrift fra www.arendalsuka.no
Dette var et arrangement i 2016

Multinational Pharmaceutical Companies: the case for investing in Norway

Arrangør
American Chamber of Commerce in Norway
Dag
Torsdag 18/8 2016 13:15 - 14:30
Arrangementstype
Samtale
Tema
Næringsliv , Helse
Språk
English
Sted
Clarion Hotel Tyholmen
Stedsbeskrivelse:
meeting room B, ground floor
 


Om arrangementet

Multinational pharmaceutical companies have developed the majority of medicines used in Norway today, yet the size of the local sector is below average and the smallest of all Nordic countries. How can the pharmaceutical industry best flourish in Norway? Join health committee parliamentarians, directors of Roche and GE Healthcare and BI's Dag Morten Dalen as we examine the best path forward.

Medvirkende
  • Dag Morten Dalen, Professor, BI Norwegian Business School
  • Bjørn Fuglaas, General Manager, GE Healthcare
  • Bård Hoksrud (FrP), Health Committee member, Norwegian Parliament
  • Elizabeth Jeffords, General Manager, Roche Norge
  • Sveinung Stensland (H), Health Committee member, Norwegian Parliament
  • Jason Turflinger, Managing Director, American Chamber of Commerce in Norway
Kontaktperson:
American Chamber of Commerce, American Chamber of Commerce, 2241 5010, amcham@amcham.no
Twitter:
Universell utforming
Rullestoltilpasset lokale
Rullestoltilpasset WC
Servering
Ja
Sidevisninger
2257